The legacy of Viagra, and its creator copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in sales , its intellectual property lapse created a wave of generic competition , significantly impacting its position . While specific businesses may seek to capitalize on related treatments , the cur